Heart Disease News and Research

Latest Heart Disease News and Research

MD Buyline identifies top emerging technologies with highest impact

This release will explain how these important technologies encourage high utilization rates across multiple service lines, bringing value to hospitals. Reimbursement changes and hospital structure enable technology purchases to generate a sequence of changes throughout service lines and dramatically impact the bottom line.

15 Jul 2010

Children's National and George Washington University receive NIH Clinical and Translational Science Award

Children's National Medical Center, in partnership with The George Washington University Medical Center, has received a prestigious Clinical and Translational Science Award (CTSA) from the National Center for Research Resources of the National Institutes of Health.

15 Jul 2010

Study reveals anti-diabetic properties of cashew seed extract

Cashew seed extract shows promise as an effective anti-diabetic, according to a new study from the University of Montreal (Canada) and the Universit- de Yaound- (Cameroun). Published in the journal Molecular Nutrition & Food Research, the investigation analyzed the reputed health benefits of cashew tree products on diabetes, notably whether cashew extracts could improve the body's response to its own insulin.

15 Jul 2010

IBM and Peking University People's Hospital build evidence-based patient centric care system

IBM and Peking University People's Hospital have built an evidence-based patient centric care (ePC3) system to enable cooperation and resource sharing among medical services providers for improved patient care.

15 Jul 2010

First triple-organ transplantation performed on young Brenham resident at Texas Children's Hospital

Texas Children's Hospital in Houston has performed the hospital's first triple-organ transplant on a 16-year-old Brenham resident. The patient, Taylor Sherrouse, underwent a 13-hour surgery on Tuesday, June 22 to replace her heart, lungs and liver, which had been severely damaged by cystic fibrosis. Taylor is one of only three pediatric patients in the country this decade to receive heart, lungs and liver in one operation.

15 Jul 2010

NIH awards $38.2M grant to Georgetown-Howard Universities Center for Clinical and Translational Science

In support of a critical partnership between Georgetown University Medical Center and Howard University, the National Institutes of Health (NIH) has awarded a $38.2 million Clinical and Translational Sciences Award to aid the universities' effort to transform health care and preventive practices in communities through medical discoveries made in laboratories and clinical settings.

15 Jul 2010

GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market

GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.

15 Jul 2010

Study links obesity to poorer memory, brain function in older women

The more an older woman weighs, the worse her memory, according to new research from Northwestern Medicine. The effect is more pronounced in women who carry excess weight around their hips, known as pear shapes, than women who carry it around their waists, called apple shapes.

15 Jul 2010

Genelex, Helix announce strategic alliance to increase availability of new DNA Drug Sensitivity Tests

Genelex and Helix have announced a personalized prescribing strategic alliance to increase the availability of important new DNA Drug Sensitivity Tests such as Plavitest and Tamoxitest. These tests and the GeneMedRx medication management software can save lives and healthcare dollars by allowing doctors to personalize their prescribing practices in order to prevent adverse medication outcomes, including treatment failures and dangerous side effects.

15 Jul 2010

Concert Medical releases 'Conductor' family of Interventional Coronary Guidewires in U.S.

Concert Medical, LLC today announced the launch of the "Conductor™" family of Interventional Coronary Guidewires to the U.S. market. These guidewires are designed to address an extensive range of coronary disease cases at a superior value. The FDA granted Concert Medical clearance for the use and sale in the U.S. of the Conductor product line in September 2009.

15 Jul 2010

U-M Hospitals and Health Centers ranked 14th among America's best hospitals

The University of Michigan Hospitals and Health Centers have been ranked among the country's best hospitals, placing 14th overall for the second consecutive year by U.S. News & World Report magazine. This year, U-M was ranked in every specialty and those rankings went up in 11 of the 16 specialties.

15 Jul 2010

Aastrom commences extension study for control patients from Phase 2 IMPACT-DCM clinical trial

Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced the initiation of an extension study for control patients from the company's ongoing open-label Phase 2 IMPACT-DCM clinical trial in patients with dilated cardiomyopathy (DCM).

14 Jul 2010

OraVerse MAA accepted for review in five key European countries

Sanofi-Aventis Deutschland GmbH and Novalar Pharmaceuticals, Inc. today announced that the Marketing Authorization Application (MAA) for OraVerse has been accepted for review by the regulatory agencies of the United Kingdom (UK), Germany, Italy, France and Spain. OraVerse is the first and only local anesthesia reversal agent that accelerates the return of normal sensation and function following routine dental procedures. OraVerse is approved for use in the U.S. by the Food and Drug Administration and sold by Novalar direct to U.S. dentists.

14 Jul 2010

Trevena completes $35M Series B financing

Trevena, Inc., the leader in discovery and development of G-protein coupled receptor biased ligands, announced today that it has completed a $35 million Series B financing. Existing investors Polaris Venture Partners and New Enterprise Associates led the round, with all other existing Trevena investors - Alta Partners, Healthcare Ventures and Yasuda Enterprise Development Company - also participating in the financing.

14 Jul 2010

Research provides better understanding of drugs used to treat, prevent cardiovascular disease

Using chemical labeling and mass spectrometry-based techniques, Mark Chance, PhD, director of the Case Western Reserve University School of Medicine Center for Proteomics and Bioinformatics and professor of physiology and biophysics; Sayan Gupta, PhD, instructor at the Case Center for Proteomics and Bioinformatics; and a research team from the University of Oxford, for the first time, were able to take a high resolution picture of the open state of a K+ channel, allowing them to comparatively analyze gating mechanisms important to heart function and nerve signaling - in addition these techniques have already permitted Case Western investigators to gain a deeper understanding of G-protein coupled receptors.

14 Jul 2010

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.

14 Jul 2010

First Lady, HHS Secretary to discuss new preventive health care coverage under Affordable Care Act

On Wednesday, at 2:15 PM EDT, First Lady Michelle Obama, Dr. Jill Biden, HHS Secretary Kathleen Sebelius will join doctors, nurses, families, and leaders from health community to make an announcement regarding new preventive health care coverage made available under the Affordable Care Act at George Washington University Hospital.

14 Jul 2010

Thomson Reuters' report on path to eliminate $3.6 trillion in wasteful healthcare spending

A report issued by Thomson Reuters and shared in part at the Aspen Ideas Festival on July 10th, indicates that a combination of better coordinated public and private sector care; stronger patient awareness of health risks and wellness; and application of improved information systems to eliminate fraud and abuse could lead to a 50% reduction in wasteful spending in healthcare, saving 3.6 trillion dollars over the next decade.

14 Jul 2010

Study evaluates physicians' experiences related to colleagues who are impaired to practice medicine

A survey of physicians finds that while most support the professional commitment to report other physicians who they feel are incompetent or impaired, such as from alcohol or drug use, when faced with this situation, many did not follow through on making a report, according to a study in the July 14 issue of JAMA.

14 Jul 2010

Commercial cholesterol measurement techniques produce mixed results: Study

The National Cholesterol Education Program maintains guidelines to assess the accuracy of methods for measuring cholesterol levels in patients. A recent study published in the journal Clinical Chemistry found that seven leading commercial methods produce results of mixed accuracy when compared to well-established techniques.

14 Jul 2010

Heart Disease News and Research

Latest Heart Disease News and Research

MD Buyline identifies top emerging technologies with highest impact

Children's National and George Washington University receive NIH Clinical and Translational Science Award

Study reveals anti-diabetic properties of cashew seed extract

IBM and Peking University People's Hospital build evidence-based patient centric care system

First triple-organ transplantation performed on young Brenham resident at Texas Children's Hospital

NIH awards $38.2M grant to Georgetown-Howard Universities Center for Clinical and Translational Science

GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market

Study links obesity to poorer memory, brain function in older women

Genelex, Helix announce strategic alliance to increase availability of new DNA Drug Sensitivity Tests

Concert Medical releases 'Conductor' family of Interventional Coronary Guidewires in U.S.

U-M Hospitals and Health Centers ranked 14th among America's best hospitals

Aastrom commences extension study for control patients from Phase 2 IMPACT-DCM clinical trial

OraVerse MAA accepted for review in five key European countries

Trevena completes $35M Series B financing

Research provides better understanding of drugs used to treat, prevent cardiovascular disease

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

First Lady, HHS Secretary to discuss new preventive health care coverage under Affordable Care Act

Thomson Reuters' report on path to eliminate $3.6 trillion in wasteful healthcare spending

Study evaluates physicians' experiences related to colleagues who are impaired to practice medicine

Commercial cholesterol measurement techniques produce mixed results: Study

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in